At a glance
ClinicalIndex Comparison RecordN/ACompleted· 153 enrolled
Drug / intervention
Disease outcome (mortality)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Review on Patients With Culture Negative Empyema
In Brief
An observational study evaluating Disease outcome (mortality) for Empyema, Pleural. Completed, enrolled 153 participants across 1 site.
Detailed Summary
Empyema is associated with a wide range of complication and mortality. It is defined by either a positive pleural fluid culture or grossly pus appearance. However, little is known about the differences in aetiology and outcome between culture-positive empyema (CPE) and culture-negative empyema (CNE). The aim of the current study is to look at the local prevalence of CNE, and compare the clinical outcome between CPE and CNE.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEmpyema, Pleural
CountriesHong Kong
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartMay 2018
Primary CompletionFeb 2020
Study CompletionMay 2020
First PostedJul 2020
TodayJul 2026
First PostedJul 20, 2020
Enrollment StartMay 3, 2018
Primary CompletionFeb 29, 2020
Study CompletionMay 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.0 years ago
Interventions
Disease outcome (mortality)other
Mortality rate between the two groups